E. J. Mayer

Purification and characterisation of recombinant rabbit plasminogen activator inhibitor-1 expressed in Saccharomyces cerevisiae

C. Reilly, L. Schultz, K. J. Hofmann, 1992 .

Plasminogen Activator Inhibitor‐1 Suppresses Endogenous Fibrinolysis in a Canine Model of Pulmonary Embolism

C. Reilly, R. Shebuski, E. J. Mayer, 1991, Circulation.

Characterization and quantitation of phospholamban and its phosphorylation state using antibodies.

W. Huckle, E. J. Mayer, R. Johnson, 2000, Biochemical and biophysical research communications.

Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat.

C. Reilly, E. J. Mayer, T. Fujita, 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

The effect of exogenous plasminogen activator inhibitor - 1 in a canine model of occlusive thrombus formation

C. Reilly, R. Shebuski, E. J. Mayer, 1991 .

The pharmacokinetics of plasminogen activator inhibitor-1 in the rabbit.

C. Reilly, R. Shebuski, E. J. Mayer, 1990, Blood.

Dissociation of Phospholamban Regulation of Cardiac Sarcoplasmic Reticulum Ca2+ATPase by Quercetin*

Jeffrey S. Smith, K. Coll, E. J. Mayer, 1996, The Journal of Biological Chemistry.

Biochemical and Biophysical Comparison of Native and Chemically Synthesized Phospholamban and a Monomeric Phospholamban Analog (*)

V. Garsky, H. Mach, Jeffrey S. Smith, 1996, The Journal of Biological Chemistry.

Structural Studies on Phospholamban and Implications for Regulation of the Ca2+‐ATPase

R. Mortishire-Smith, V. Garsky, E. J. Mayer, 1998, Annals of the New York Academy of Sciences.